Skip to content

Neurophysiological mechanisms underlying low-frequency repetitive transcranial magnetic stimulation for generalized anxiety disorder: a functional near-infrared spectroscopy study

Research on the Construction of a Machine Learning Prediction Model for the Therapeutic Effect of rTMS in Generalized Anxiety Disorder Based on fNIRS Technology

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500106614
Enrollment
Unknown
Registered
2025-07-28
Start date
2025-08-15
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Generalized anxiety disorder

Interventions

Active rTMS stimulation group:1.Instruments: The rTMS device (Shenzhen YINGCHI Technology Co., Ltd.) with 8-shaped coil is adopted, and the 8-shaped coil is employed. 2.Stimulation parameters: The sti
3.Stimulation target: the stimulation location is set on the right dorsolateral prefrontal cortex (DLPFC) based on the 10-20 electroencephalogram (EEG) positioning system, and the coil must be tangent
(2) They also need to remove metal glasses, watches, hearing AIDS, etc. During the treatment period, patients should be required to maintain the same posture to avoid off-target stimulation.
Sham rTMS stimulation group:The treatment will be administered using rTMS device with the 8-shaped sham coil (Shenzhen YINGCHI Technology Co., Ltd.). The coil will not be electrified, and will generat

Sponsors

Sichuan Province Bayi Rehabilitation Center (Sichuan Province Rehabilitation Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Aged between 18 and 65 years with no gender restrictions. 2.Right-handedness (Edinburgh Handedness Inventory score > 40); 3.Meeting the diagnostic criteria for GAD according to the fifth edition of Diagnostic and Statistical Manual of Mental Disorders (DSM-V); 4.Hamilton Anxiety Scale (HAMA) scores >=14 points, and Hamilton Depression Rating Scale-24 (HAMD-24) scores < 7 points; 5.No prior use of anxiolytic medications before enrollment, or discontinuation of anxiolytic medications for at least two weeks; 6.No history of drug or alcohol abuse; 7.Voluntarily participate in the research and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Diagnosis of depression; 2.Suffering from endocrine system disorders (e.g., diabetes mellitus, thyroid diseases); 3.Presence of neurological disorders (e.g., Parkinson's disease, dementia); 4.Combined with other psychiatric disorders (e.g., bipolar disorder, obsessive-compulsive disorder, schizophrenia) 5.Having suicidal ideation or behavior; 6.Pregnancy or lactation; 7.Suffering from severe cardiac disease; 8.With hearing impairments; 9.Having a history of epilepsy; 10.Presence of intracranial or metallic implants.

Design outcomes

Primary

MeasureTime frame
Hamilton Anxiety Scale, HAMA Score;

Secondary

MeasureTime frame
Generalized anxiety disorder-7, GAD-7 Score;Pittsburgh Sleep Quality Index, PSQI;Social Disability Screening Schedule, SDSS Score;Hamilton Depression Scale, HAMD-24 Score;

Countries

China

Contacts

Public ContactJuan Li

Sichuan Province Bayi Rehabilitation Center (Sichuan Province Rehabilitation Hospital)

785939016@qq.com+86 182 2449 4675

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026